알지노믹스

476830KOSDAQView the 바이오 R&D sectorTheme Bio & healthcare

23,400KRWMarket close of 10/20 (Tue)

Down -1.89%-450KRWMarket close of 10/20 (Tue)

Preliminary value right after the close — replaced by official KRX data tomorrow morningClose of 10/21 (Wed)25,100KRWUp +7.26%

Preliminary · just after the close · replaced by official KRX data tomorrow morning

Open
23,950
High
24,350
Low
22,250
Day range
Day range low 22,250 high 24,350, open 23,950, close 23,400, previous close 23,850
Volume
23×10K shares
5.3B KRW 0.65× the 20-session average

Market close of 10/20 (Tue)

Usual range

Nothing unusual in the 5 checked items

Free · no sign-inSource from 2021-05-17

Points to check

  • Earningsnot verifiedOutside financial data coverage, so not verified
  • Daily moveusual range-1.89%-1.89%, 0.3× the usual (20-session average ±5.71%)
    That day -1.89% · usual ±5.71% · large-move threshold ±11.4%
  • Trading valueusual range0.6×5.3B KRW, 0.6× the 20-session average
    0.65× the 20-session average · check threshold 3×

The other 3 are within the usual range

  • Recent filings0Last 14 days
  • Foreign & institutional-1.6B KRWusual range
  • Data date10/20 (Tue)Market close
See the full check report

Same sector · 바이오 R&D

Down -2.19%

· 16 of 64 stocks up, preferred shares excluded · trading value 190.5B KRW

Same sector · top by trading value
Stock20DChangeTrading value
알테오젠Close over the last 20 sessions -9.6%Down -3.35%51.1B KRW
올릭스Close over the last 20 sessions -12.2%Down -4.03%19.1B KRW
디앤디파마텍Close over the last 20 sessions -11.8%Down -1.93%15.1B KRW
리가켐바이오Close over the last 20 sessions -15.4%Down -1.41%12.1B KRW
프로티나Close over the last 20 sessions +31.8%Up +7.38%10.0B KRW

Schedule

  • Next data 10/22 (Thu) after 08:50

Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 81% of trading value, about 92% of market capitalisation. Coverage status →

For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.